A. Möller

发表

IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

D. Schadendorf, M. Sticherling, M. Worm, 1993, Journal of immunology.

The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.

N. Undre, K. Iwasaki, A. Möller, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

W. Lehmacher, E. Holler, J. Kempeni, 1990, Blood.

Production of interleukin-6 by human mast cells and basophilic cells.

U. Lippert, G. Kolde, B. Henz, 1996, The Journal of investigative dermatology.

Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.

D. Schadendorf, J. Norgauer, M. Artuc, 1998, Journal of immunology.

Blocking lymphotoxin‐β receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) expression and leucocyte margination in chronic DSS‐induced colitis

D. Männel, F. Obermeier, W. Falk, 2004 .

Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease

H. Schwanitz, B. Czarnetzki, T. Rosenbach, 1985, The British journal of dermatology.

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

W. Lehmacher, E. Holler, J. Kempeni, 1990, Blood.

Human mast cells produce IL-8.

D. Schadendorf, T. Luger, P. Welker, 1993, Journal of immunology.

Pharmacological modulation of IL‐6 and IL‐8 secretion by the H1‐antagonist decarboethoxy‐loratadine and dexamethasone by human mast and basophilic cell lines

B. Czarnetzki, U. Lippert, A. Möller, 1995, Experimental dermatology.

Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies

B. Burkhardt, C. Hemmelmann, F. Locatelli, 2020, Bone Marrow Transplantation.

Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1‐ and H2‐receptor antagonists

P. Welker, M. Artuc, U. Lippert, 2000, Experimental dermatology.

In vitro generation of chemotactic leukotrienes from unfractionated murine epidermal cells.

H. Schwanitz, B. Czarnetzki, A. Möller, 1986, The Journal of investigative dermatology.

Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1).

L. Ashman, P. Welker, B. Czarnetzki, 1994, The Journal of investigative dermatology.

Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.

P. Welker, W. Nürnberg, B. Czarnetzki, 1996, International archives of allergy and immunology.

Detection of Intracellular Interleukin-8 in Human Mast Cells: Flow Cytometry as a Guide for Immunoelectron Microscopy

A. Grützkau, U. Lippert, B. Henz, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients.

B. Meiser, B. Reichart, P. Uberfuhr, 1998, Transplantation proceedings.

Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients

N. Undre, A. Möller, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Erythema elevatum diutinum – evidence for disease‐dependent leucocyte alterations and response to dapsone

B. Henz, A. Möller, J. Grabbe, 2000, The British journal of dermatology.

THE DISPOSITION OF 14 C-LABELED TACROLIMUS AFTER INTRAVENOUS AND ORAL ADMINISTRATION IN HEALTHY HUMAN SUBJECTS

N. Undre, K. Iwasaki, A. Möller, 1999 .

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients

N. Undre, P. Wallemacq, E. Sokal, 1998, European Journal of Drug Metabolism and Pharmacokinetics.

Human Mast Cells IL-8 Receptor Type CXCR 1 and CXCR 2 on Expression and Functional Activity of the

D. Schadendorf, J. Norgauer, M. Artuc, 1998 .

Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.

E. Holler, J. Kempeni, E. Hiller, 1991, Bone marrow transplantation.

Systemic Release of Tumor Necrosis Factor Alpha in Human Allogeneic Bone Marrow Transplantation: Clinical Risk Factors, Prognostic Significance, and Therapeutic Approaches

W. Wilmanns, E. Holler, J. Kempeni, 1992 .

Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.

P. Welker, A. Grützkau, U. Lippert, 1998, Molecular biology of the cell.

Expression and functional activity of the IL-8 receptor by human mast cells

D. Schadendorf, M. Artuc, B. Czarnetzki, 1994 .

Increase of TNF-α Serum Levels in Major Transplant-Related Complications of Human Bone Marrow Transplantation— Association with Acute Graft-Versus-Host Disease and Activation of Host Macrophages

W. Lehmacher, W. Wilmanns, E. Holler, 1990 .

Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.

P. Welker, U. Lippert, B. Henz, 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

Role of Antigen-Induced Cytokine Release in Atopic Pruritus

U. Lippert, B. Henz, I. Ramboer, 1998, International Archives of Allergy and Immunology.

Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.

W. Falk, D. Männel, F. Obermeier, 2004, Clinical and experimental immunology.